AI in Diabetic Retinopathy Screening

Introduction: Diabetic retinopathy is a common diabetes-related eye complication that can lead to vision impairment and blindness if not detected and treated early.

Background: Traditional diabetic retinopathy screening involves retinal examination and fundus photography, which require trained healthcare professionals and specialized equipment.

Study Objective: To explore the role of artificial intelligence in diabetic retinopathy screening, focusing on diagnostic accuracy, early detection, and clinical applications.

AI-Based Screening: Examine how AI algorithms and deep learning models analyze retinal images to identify signs of diabetic retinopathy.

Diagnostic Accuracy: Evaluate the sensitivity, specificity, and accuracy of AI-based screening systems in detecting different stages of diabetic retinopathy.

Disease Classification: Assess the ability of AI systems to classify diabetic retinopathy into different severity levels, including mild, moderate, severe, and proliferative stages.

Early Detection: Explore how AI-assisted screening supports early diagnosis and timely referral for ophthalmological evaluation and treatment.

Clinical Applications: Investigate the integration of AI screening systems into hospitals, diabetes clinics, primary healthcare centres, and telemedicine services.

Challenges and Limitations: Examine issues related to image quality, algorithm reliability, data privacy, accessibility, cost, and the need for clinical validation.

Conclusion: Artificial intelligence has the potential to improve diabetic retinopathy screening through faster image analysis, early detection, and better access to eye care services. However, clinical oversight remains essential.